Mechanisms of Resistance to Chimeric Antigen Receptor T Cell Therapy

被引：2
|
作者：
Johnson, Grace A. [1 ]
Locke, Frederick L. [2 ]
机构：
[1] Univ S Florida, Morsani Coll Med, 560 Channelside Dr, Tampa, FL 33602 USA
[2] H Lee Moffitt Canc Ctr & Res Inst, Dept Blood & Marrow Transplant & Cellular Immunoth, 12902 USF Magnolia Dr,Suite 3057, Tampa, FL 33612 USA
来源：
HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA | 2023年 / 37卷 / 06期
关键词：
CAR T-cell therapy; Cellular immunotherapy; Large B-cell lymphoma; Chronic lymphocytic leukemia; Acute lymphocytic leukemia; Tumor microenvironment; AXICABTAGENE CILOLEUCEL; LYMPHOMA; OUTCOMES; MUTATIONS; LEUKEMIA; TP53;
D O I：
10.1016/j.hoc.2023.07.003
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
[No abstract available]
引用
收藏
页码：1189 / 1199
页数：11
相关论文
共 50 条
  • [21] Chimeric antigen receptor T cell therapy for multiple myeloma
    Hasegawa, Kana
    Hosen, Naoki
    INFLAMMATION AND REGENERATION, 2019, 39 (1)
  • [22] Pseudoprogression as complication of Chimeric Antigen Receptor T Cell therapy
    Martens, T.
    Schroeder, T.
    Chitadze, G.
    Yalcin, F.
    Heinen, C.
    Nakov, P.
    Fast, B.
    Albici, A. -M
    Spath, N.
    Sprenger, L.
    Kramp, L. -J
    Ritgen, M.
    Wellnitz, D.
    Simon, M.
    Lippross, S.
    Idelson, I. Iaccarino
    Klapper, W.
    Fransecky, L.
    Valerius, T.
    Schub, N.
    Pott, C.
    Baldus, C. D.
    Stoelzel, F.
    ONCOLOGY RESEARCH AND TREATMENT, 2023, 46 : 199 - 199
  • [23] CHIMERIC ANTIGEN RECEPTOR (CAR) T CELL THERAPY FOR ASPERGILLOSIS
    Kumar, P.
    Wurster, S.
    daSilva, T.
    Hauser, P.
    Neelapu, S. S.
    Kontoyiannis, D.
    CYTOTHERAPY, 2024, 26 (06) : S10 - S11
  • [24] Chimeric antigen receptor T-cell therapy toxicities
    Greenbaum, Uri
    Kebriaei, Partow
    Srour, Samer A.
    Olson, Amanda
    Bashir, Qaiser
    Neelapu, Sattva S.
    Rezvani, Katayoun
    Shpall, Elizabeth J.
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2021, 87 (06) : 2414 - 2424
  • [25] Mechanisms and Management of Chimeric Antigen Receptor T-Cell Therapy-Related Toxicities
    Dholaria, Bhagirathbhai R.
    Bachmeier, Christina A.
    Locke, Frederick
    BIODRUGS, 2019, 33 (01) : 45 - 60
  • [26] Chimeric Antigen Receptor (CAR) T-Cell Therapy
    Pagel, John M.
    West, Howard
    JAMA ONCOLOGY, 2017, 3 (11) : 1595 - 1595
  • [27] The Promise of Chimeric Antigen Receptor T-Cell Therapy
    Frey, Noelle V.
    Porter, David L.
    ONCOLOGY-NEW YORK, 2016, 30 (10): : 880 - +
  • [28] Chimeric antigen receptor T-cell therapy for glioblastoma
    Rodriguez, Analiz
    Brown, Christine
    Badie, Behnam
    TRANSLATIONAL RESEARCH, 2017, 187 : 93 - 102
  • [29] Biomarkers in chimeric antigen receptor T-cell therapy
    Kong, Weimin
    Lacey, Simon F.
    Melenhorst, Jan Joseph
    Fraietta, Joseph A.
    BIOMARKERS IN MEDICINE, 2018, 12 (05) : 415 - 418
  • [30] Parkinsonism Following Chimeric Antigen Receptor T Cell Therapy
    Gudera, Jonas A.
    Baehring, Joachim M.
    Karschnia, Philipp
    JAMA NEUROLOGY, 2024, 81 (09) : 958 - 965
12345